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Abstract
Background/Aim. During choledocholitiasis inflamma-
tory oxidant stress involves the promotion of mitochondrial
dysfunction through an intracellular oxidant stress in hepa-
tocytes leading mainly to necrosis and less to apoptosis. The
product of oxidative stress, malondialdehyde (MDA), is ex-
tremely cytotoxic and damages cell membranes and intra-
cellular macromolecules. The toxicity of MDA is based on
its ability to act as a mutagenic agent in a cell. Therefore, the
aim of this prospective study was to establish correlation of
the parameters of inflammation and biochemical markers of
cholestasis with the intensity of oxidative stress in patho-
genesis of liver function disorders. Methods. Seventy adult
subjects of either sex included in the study were devided
into two groups: I – 40 patients with obstructive icterus
caused by choledocholithiasis, and II – 30 healthy individu-
als. All the participants were subjected to a clinical, labora-
tory and ultrasonic check-up at the Internal Department of
the Military Hospital in Niš. The parameters of oxidative
stress: MDA, a measure of lipid peroxidation, and inflam-
mation parameters: C-reactive protein (CRP), fibrinogen,
albumins, number of leukocytes (Leu), granulocytes ( Gr),
lymphocytes (Ly) and monocytes (Mo) and biochemical
markers of cholestasis: activity of ƣ-glutamyltransferase (ƣ-
GT) and alkaline phosphatase (AP) enzymes, the level of
total, direct and indirect bilirubin were determined by stan-
dard biochemical methods. Results. Lower values of albu-
min (p < 0.001), and significantly higher values of fibrino-
gen (p < 0.05) and CRP (p < 0.001) were found in the blood
of the patients with cholestasis due to choledocholithiasis in
relation to the controls. Significantly higher values of Leu (p
< 0.01) and Gr (p < 0.001) with decreasing number of Ly (p
< 0.001) and Mo (p < 0.001) were found in blood of the
patients with cholestasis due to choledocholithiasis in rela-
tion to the control. Similarly, higher values of ƣ-GT, and AP
(p < 0.001), as well as the level of total, direct and indirect
bilirubin (p < 0.001) were found in blood of the patients
with cholestasis due to choledocholithiasis in relation to the
controls. The concentration of MDA (p < 0.001) was in-
creased in the patients with choledocholithiasis in relation to
the controls. There was a significant positive linear correla-
tion of the number of leukocytes (r = 0.51, p < 0.05) and
the concentration of total (r =  0.87, p < 0.01),  direct  (r
= 0.85, p < 0.01) and indirect (r  = 0.88, p < 0.01) bilirubin
with the concentration of MDA in the group of patients
with choledocholithiasis. Conclusion. Neutrophils and the
levels of total, direct and indirect bilirubin have a significant
positive linear correlation with the level of lipid peroxida-
tion in patients with choledocholithiasis. Neutrophilia and
hiperbilirubinemia observed in this way represent important
parameters in estimating the level of liver tissue damage in
choledocholithiasis.
Key words:
choledocholithiasis; oxidative stress; cholestasis;
inflammation.
Apstrakt
Uvod/Cilj. U toku holedoholitijaze inflamatorni oksidativ-
ni stres uzrokuje mitohondrijalnu disfunkciju kroz intrace-
lularni oksidativni stres u hepatocitima dovodeýi uglavnom
do nekroze, a reĀe i do apoptoze. Produkt oksidativnog
stresa, malondialdehid (MDA), izuzetno je citotoksiÿan i
ošteýuje  ýelijske membrane i intraýelijske makromolekule.Volumen 70, Broj 2 VOJNOSANITETSKI PREGLED Strana 171
Damnjanoviý Z, et al. Vojnosanit Pregl 2013; 70(2): 170–176.
Cilj ovog istraživanja bio je utvrĀivanje povezanosti para-
metara inflamacije i biohemijskih markera holestaze sa in-
tenzitetom oksidativnog stresa u patogenezi poremeýaja
funkcije jetre. Metode. Ukupno 70 odraslih osoba oba pola
ukljuÿenih u ispitavanje bilo je podeljeno u dve grupe: grupa
I – 40 bolesnika sa opstruktivnom žuticom izazvanom ho-
ledoholitijazom i grupa II – 30 zdravih ispitanika. Svi uÿes-
nici ispitani su kliniÿki, laboratorijski i ultrazvuÿno na Inter-
nom odeljenju Vojne bolnice u Nišu. Parametri oksidativ-
nog stresa: MDA, mera lipidne peroksidacije, inflamatorni
parametri: C-reaktivni protein (CRP), fibrinogen, albumini,
broj leukocita (Leu), granulocita (Gr), limfocita (Ly) i mo-
nocita (Mo); i biohemijski markeri holestaze: aktivnosti en-
zima J-glutamiltransferaze (J-GT) i alkalne fosfataze (AP),
nivo ukupnog, direktnog i indirektnog bilirubina, odreĀivani
su standardnim biohemijskim metodama. Rezultati. Niže
vrednosti albumina (p < 0,001) i znaÿajno veýe vrednosti fi-
brinogena (p < 0,05) i CRP (p < 0,001) naĀene su kod bole-
snika sa holestazom izazvanom holedoholitijazom u odnosu
na kontrolu. Znaÿajno veýa vrednost Leu (p < 0,01) i Gr (p
< 0,001), uz opadanje broja Ly (p < 0,001) i Mo (p < 0,001),
uoÿena je u grupi bolesnika sa holestazom izazvanom hole-
doholitijazom u odnosu na kontrolnu grupu. Poveýane vre-
dnosti enzima J-glutamiltransferaze (J-GT) i alkalne fosfata-
ze (AP) (p < 0,001), kao i nivo ukupnog, direktnog i indi-
rektnog bilirubina (p < 0,001) naĀene su u krvi bolesnika sa
holedoholitijazom u odnosu na kontrolu. Koncentracija
MDA bila je povišena kod bolesnika sa holedoholitijazom u
odnosu na kontrolnu grupu. Ustanovljena je znaÿajna pozi-
tivna linearna povezanost izmeĀu broja leukocita (r = 0,51,
p < 0,05) i koncentracije ukupnog (r = 0,87, p < 0,01), di-
rektnog  (r = 0,85,  p < 0,01)  i  indirektnog  (r = 0,88,
p < 0,01) bilirubina sa koncentracijom MDA u grupi boles-
nika sa holedoholitijazom. Zakljuÿak. Neutrofili i nivo
ukupnog, direktnog i indirektnog bilirubina pokazuju zna-
ÿajnu pozitivnu linearnu povezanost sa stepenom lipidne
peroksidacije kod bolesnika sa holedoholitijazom. U skladu
sa tim, neutrofilija i hiperbilirubinemija predstavljaju znaÿaj-
ne parametre u proceni stepena ošteýenja jetrinog tkiva kod
holedoholitijaze.
Kljuÿne reÿi:
holedoholitijaza; stres, oksidativni; holestaza;
zapaljenje.
Introduction
The biochemical syndrome occurring in patients with
choledocholithiasis is called cholestasis 
1. Hyperbilirubinae-
mia, which is the integral part of cholestasis syndrome, leads
to liver function damage, dysfunction of gastrointestinal bar-
rier, immunodeficiency, coagulation disorders and disorders
in detoxification, accompanied by impeded wound healing 
2.
Choledocholitiasis (CHDL) also initiates an inflamma-
tory response 
3. The mechanism by which cholestasis initi-
ates an inflammatory response in the liver, however, is not
known. In the study of Allen et al. 
4 two mechanisms of in-
flammation were examined. Firstly, activation of Toll-like
receptor 4 (TLR4), either by bacterial lipopolysaccharide or
by damage-associated molecular pattern molecules released
from dead hepatocytes, triggers an inflammatory response.
Secondly, bile acids act as inflammagens, and directly acti-
vate signaling pathways in hepatocytes that stimulate pro-
duction of proinflammatory mediators. Koutelidakis et al. 
5
have reported that the development of inflammatory re-
sponse in the liver is a very complex process, involving a
coaction of numerous pro- and anti-inflammatory mediators
and immune cells.
Numerous experimental studies proved more intense
oxidative stress and increased intensity of lipid peroxidation
in the plasma and liver tissue in animals with experimentally
induced cholestasis 
6–7.
Studies have demonstrated that oxidative stress occurs
in human livers with choledocholitiasis 
3, 5, 8. Jaeschke 
8 has
reported that bile duct obstruction is associated with hepato-
cellular injury, cholangiocyte proliferation, stellate cell acti-
vation, Kupffer cell activation, oxidative stress, inflamma-
tion and fibrosis.
Oxidative stress is a process of tissue injury due to the
free radicals effect. They can damage almost all important
biomolecules and cells in an organism 
9. Inflammatory oxi-
dant stress insufficient to directly cause cell damage can in-
duce transcription of stress defense genes including antioxi-
dant genes 
8.
The mechanism of reactive oxigen species (ROS)-
induced cell killing during inflammation involves the pro-
motion of mitochondrial dysfunction through an intracellular
oxidant stress in hepatocytes leading mainly to necrosis and
less to apoptosis 
10. The products of oxidative stress, such as
malondialdehyde (MDA), have been found in in the blood of
patients with cholestasis. These products are extremely cy-
totoxic and damage cell membranes and intracellular mac-
romolecules 
9. MDA is an end product of lipid peroxidation
and is a good indicator of oxidative stress. Consistent with
previously reported findings from studies of obstructive
jaundice in rodents 
11,12, the toxicity of MDA is based on its
ability to act as a mutagenic agent in a cell 
13.
There is a lack of information about the correlation
between the inflammatory parameters and markers of chole-
stasis with intensity of lipid peroxidation in the patients with
choledocholitiasis.
Therefore, the aim of this study was to establish the cor-
relation of parameters of inflammatory disorders and char-
acteristic biochemical markers of cholestasis with the inten-
sity of lipid peroxidation in pathogenesis of liver function
disorders. Such knowledge in patients with choledocholithia-
sis may contribute to better understanding of the disease and
possibly to its more rational treatment.
Methods
The study included 70 subjects divided into two groups:
the group I – 40 patients with obstructive jaundice caused by
choledocholithiasis and the group II (control) – 30 healthy
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The patients with extrahepatic cholestasis due to me-
chanical obstruction caused by choledocholithiasis were in-
cluded in the study. The obstruction of biliary ducts caused
by other factors was not considered.
The diagnosis of obstructive icterus was made accord-
ing to anamnestic data, clinical features, and biochemical and
ultrasound examination of biliary ducts. For the ultrasound
examination of biliary ducts in the supine position a Sono et
Medison Co. Ltd ultrasound was used.
All the patients were anamnaestically and clinically ob-
served at the Internal Department of Military Hospital in Niš.
Basic biochemical indicators and parameters of oxidative
stress were determined in Biochemical Laboratory of Mili-
tary Hospital in Niš and the Laboratory of the Biochemistry
Institute at the Faculty of Medicine in Niš.
All the patients with choledocholitiasis were tested in
the first three days since the occurrence of cholestasis syn-
drome and before surgery or endoscopic retrograde cholan-
giopancreatography (ERCP) with papillotomy.
Biochemical analysis
Inflammatory and cholestasis parameters: C-reactive
protein (CRP), fibrinogen, albumins, sedimentation (SE)
rate, number of leukocytes (Leu), granulocytes (Gr), lym-
phocytes (Ly), monocytes (Mo), activity of Ȗ-glutamy-
ltransferase (Ȗ-GT) and alkaline phosphatase (AP) and the
level of bilirubin were determined.
The previously mentioned biochemical parameters
were determined by the ready tests produced by Ellitech
Company, on the biochemical analyzer BTS–370 (Bio–
system).
The intensity of lipid peroxidation in plasma was meas-
ured spectrophotometrically, and based on the thiobarbituric
response products as described by Ohkawa et al. 
14. Malon-
dialdehyde (MDA – lipid peroxidation end-product) concen-
tration was expressed as ȝmol/L, using the MDA molecular
absorbance coefficient (1.56 u 10
-5 mol cm
-1).
Statistical analysis
The data were analyzed by means of the commercially
available statistic software package (SPSS
® for Windows, v.
9.0, Chicago, USA) using the Student’s t-test and F
2 test. The
results were presented as means ±/SD. Statistical signifi-
cance was set to p < 0.05. To determine the correlation of the
parameters of inflammatory disorders and characteristic bio-
chemical markers of cholestasis with the intensity of lipid
peroxidation the Pearson's correlation coefficient (r) was
used.
Results
The demographic characteristics in the control group and
the patients with choledocholitiasis are shown in Table 1.
Participants of both groups did not differ in gender and
age structure. Out of the total number of studied subjects,
there were 40 patients with extrahepatic cholestasis caused
by choledocholitiasis and 30 control (healthy) individuals; 37
(53%) were men and 33 (47%) women. The average age of
the patients was 58.8 ± 15.9 years.
The clinical characteristics of the patients with choledo-
cholitiasis are shown in Table 2.
Table 2
Clinical characteristics of the patients with
choledocholitiasis
Clinical characteristics Number of patients (%)
Icterus 21 (52.5)
Subicterus 19 (47.5)
Abdominal pain 40 (100)
Nausea and vomiting 23 (57)
Aholic stool 32 (80)
Abdominal pain was presented in all the patients with
choledocholitiasis and 89% of the patients had aholic stool.
All the patients with choledocholitiasis had icterus or subic-
terus while nausea and vomiting were registered in about
half of the patients.
The level of inflammation and cholestasis, measured
via biochemical indicators, and the intensity of lipid peroxi-
dation measured in the form of MDA, are shown in Table 3.
In the patients with choledocholithiasis, statistically
significantly lower values of albumins (p < 0.001), as well as
significantly higher values of fibrinogen (p < 0.05) and CRP
(p < 0.001) compared to the control group were found. Sta-
tistically much higher values of SE (p < 0.05), Leu (p <
0.01), and Gr (p < 0.001), with a decreasing number of Ly (p
< 0.001) and Mo (p < 0.001) were found in the group of pa-
tients with choledocholithiasis compared to the control
group.
The activity of alkaline phosphatase (AP) and Ȗ-GT and
the levels of total, direct and indirect bilirubin in the blood
plasma of the patients with extrahepatic cholestasis caused
by choledocholithiasis showed a significant increase (p <
0.001) compared to the control group.
Also, the values of MDA were significantly increased (p
< 0.001) in the patients with extrahepatic cholestasis caused by
choledocholithiasis, compared to the control group.
Table 1
Demographic characteristics in the control group and the patients with choledocholitiasis (CHDL)
Parameter Control CHDL Total
Age (years), ʉ ± SD 55.5 r 18.0 61.4 r 14.1 58.8 r 15.9
Gender, n (%)
male 18 (60) 19 (47.5) 37 (53)
female 12 (40) 21 (52.5) 33 (47)
F
2 test and Student's t-test did not reveal any significant differences in gender distribution and in the average age between
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The correlation of biochemical parameters of inflam-
mation and cholestasis with the intensity of lipid peroxida-
tion in the patients with choledocholithiasis is shown in Ta-
ble 4.
The concentration of fibrinogen (r = 0.53, p < 0.05) and
CRP values (r = 0.55, p < 0.05) were in a direct positive lin-
ear correlation with the intensity of lipid peroxidation in
healthy individuals, but the correlation was not present in the
patients with choledocholithiasis There was a significant
positive linear correlation between the number of leukocytes
(r = 0.51,  p  <  0.05) and the concentration of MDA in the
group of patients with choledocholithiasis, while the other
inflammation parameters  in this group  did not show such
correlation.
The concentration of total (r = 0.87, p < 0.01), direct
(r = 0.85, p < 0.01) and indirect (r = 0.88, p < 0.01) biliru-
bin was in statistically significant positive linear correlation
with the level of lipid peroxidation, while the other bio-
chemical markers of cholestasis do not show such correla-
tion.
Discussion
In this study the patients with choledocholitiasis were
examined in the first three days since the occurrence of cho-
lestasis syndrome. Abdominal pain, icterus or subicterus
were presented in all the patients with choledocholitiasis.
Nausea and vomiting were registered in about half of the pa-
tients while 89% of the patients had aholic stool.
Cholestasis syndrome includes liver function disorder
due to the obstruction of bile drainage into the intestine, with
the consequent retention of bile constituents in liver and their
regurgitation in the blood 
15, 16.
The intensity of oxidative stress, measured as MDA
values, was significantly increased in patients with chole-
stasis caused by choledocholithiasis (p < 0.001). This is in
accordance with numerous experimental and clinical stud-
ies 
3, 5–8. Obstructive jaundice points to intestinal oxidative
stress, which can be the key factor in the loss of intestinal
barrier and development of septic complications in these
patients 
13.
Table 3
The results of laboratory parameters in the control group and the patients
with choledocholitiasis (CHDL)
Parameter Control CHDL
Albumin (g/L) 46.1 r 4.3 36.7 r 6.6***
Fibrinogen (g/L) 3.5 r 1.1 5.1 r 1.2*
CRP (mg/dL) 4.7 r 1.3 11.2 r 7.1***
Leu (G/L) 6.1 r 1.4 9.9 r 6.3**
Ly (%) 28.8 r 9.4 15.3 r 8.2***
Mo (%) 8.5 r 3.0 5.2 r 3.9***
Gr (%) 62.2 r 8.9 79.4 r 10.6***
AP (U/L) 81.4 r 37.7 385.0 r 459.0***
Ȗ-GT (U/L) 24.1 r 6 364.0 r 382.0***
Bil – total (mmol/L)
1 9.5 r 2.8 123.2 r 101.1***
Bil – direct (mmol/L)
1 3.01 r 1.09 55.1 r 39.4***
Bil – indirect (mmol/L)
1 6.6 r 2.4 73.6 r 61.8***
MDA (ȝmol/L) 21.6 r 2. 51.2 r 8.6***
CRP – C-reactive protein; Leu – leukocytes; Ly – lymphocytes; Mo – monocytes;
Gr – granulocytes; AP – alkaline phosphatase; J-GT –  J-glutamyl transferase; Bil-bilirubin;
MDA – malondialdehyde.
*p < 0.05; **p < 0.01; ***p < 0.001 compared to the control.
Table 4
Correlation between biochemical parameters of inflammation and cholestasis with the intensity
of lipid peroxidation in the control group and the patients with choledocholitiasis (CHDL)
Parameter Correlation with MDA (r)
Control CHDL CHDL (r)
Albumin (g/L) -0.05 -0.11
Fibrinogen (g/L) 0.53* -0.23
CRP 0.55* -0.24
Leu (G/L)
 3  0.15 0.51*
Ly (%)
4 0.34 0.02
Mo (%)
5 -0.10 0.32
Gr (%)
6 -0.33 -0.13
AP (U/l) 0.12 0.01
J-GT (U/L) 0.15 -0.03
Bil – total (ȝmol/L) -0.05 0.87**
Bil – direct (ȝmol/L) 0.05 0.85**
Bil – idirect (ȝmol/L) 0.15 0.88**
CRP – C-reactive protein; Leu – leukocytes; Ly – limphocytes; Mo – monocytes; Gr – granulocytes;
AP – alkaline phosphatase; J-GT –  J-glutamyl transferase; Bil-bilirubin; MDA – malonidialdehyde.
r – Pearson's correlation coefficient
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Correlation of the inflammation parameters and the
intensity of lipid peroxidation
Albumins as negative inflammatory reactants and
markers of impaired synthetic liver function were signifi-
cantly lower in patients with extrahepatic cholestasis. A de-
crease in the concentration of albumin indicates liver disor-
der lasting longer than three weeks, but in rapidly progres-
sive diseases, the decrease can occur even sooner 
17.
In this study, the values of both fibrinogen (positive in-
flammatory reactant) and CRP were significantly higher in
the patients with cholestasis. A significant increase in fi-
brinogen concentrations, as an inflammatory parameter in
patients with obstructive icterus, is in accordance with the re-
sults of other authors 
18. Inflammatory cytokines inducing fi-
brinogen transcription in the liver, tissue factor in mono-
cytes, endothelial and muscle cells, VIII factor in the liver,
PAI-I in the liver and adipocytes, lead to procoagulation
states. There was also a positive correlation between fibrino-
gen and C-reactive protein in healthy common population 
19.
The results of this study show that choledocholithiasis
leads to increased number of leukocytes, with the decrease in
lymphocyte and monocyte percentage.
The increase in the number of granulocytes is in accor-
dance with the results of other authors stating that the clinical
problem in patients with obstructive icterus is mainly the
consequence of disorders in neutrophil function 
20. The ex-
perimental study by Gujarol et al. 
21 shows that activated
neutrophils take part in the liver parenchymal damage during
a short period of obstructive icterus manifestation (during 5
days from the obstruction of mutual biliary duct). Increased
number of leukocytes, neutrophils, hemotaxic neutrophils,
increased production of superoxide radicals and increased
expression of adhesive molecules, damage endothelial cells
of liver sinusoids and apoptosis, playing thus the key role in
organic dysfunction 
22, 23.
Monocytes start to accumulate in three days from the
beginning of obstruction and their number increases syn-
chronously with the increase of concentration of intercellular
adhesion molecule (ICAM) – 1 during obstructive jaundice
development. Simultaneously, their number returns to nor-
mal on the 14th day form the obstruction of ductus choledo-
chus, which indicates the time trend of change in cholestatic
organism 
24. These results are not in accordance with the
changes in the number of monocytes registered in our study.
One of the possible explanations is that all the patients were
tested in the first three days since the occurrence of cholesta-
sis syndrome during which there was no significant increase
in the number of monocytes.
There is a positive linear correlation of fibrinogen con-
centration (r = 0.53,  p  <  0.05) and CRP values (r =  0.55,
p < 0.05) with the intensity of lipid peroxidation in the con-
trol group of the patients. The correlation of inflammatory
markers synthesized in the liver, such as albumins, fibrino-
gen and CRP, with the level of oxidative stress, has not been
proven in the patients with extrahepatic cholestasis. This is in
accordance with the results of other authors stating that dys-
function of hepatocytes and damaged synthetic liver function
in the states of cholestasis make the significance of these
markers quite uncertain. Therefore, extrahepatic cholestasis
should involve analysis of other markers of inflammation,
such as tumor necrosis factor alpha (TNF-a), interleukin
(IL)-1, IL-6, number of leukocytes and neutrophils 
5.
There was a significant positive linear correlation of the
number of leukocytes (r = 0.51, p < 0.05) with the intensity
of lipid peroxidation. Namely, this knowledge in patients
with choledocholithiasis might not only contribute to better
understanding of pathophysiology of the disease, but also to
a possible improvement of its treatment. Accumulated neu-
trophils are adhered to vascular endothelium due to increased
expression of adhesive molecule ICAM-1 and they penetrate
into mucosa of involved organs and hepatic tissue, causing
oxidative stress and tissue damage 
25, 26. These neutrophiles
represent the source of large quantity of free radicals that
damage the mentioned structures and increase the content of
carbonyl groups 
27, 28.
The correlation of the number of leukocytes with the
intensity of lipid peroxidation is in accordance with the re-
sults of other authors indicating the correlation between the
oxidative stress and inflammation via cytokine TNF-a, trans-
forming growth factor beta (TGF-ȕ), IL-1b and IL-6 
29–31 and
transcription factor, NFkB 
32. NF-kB plays a central role in
the transcription of cytokines, adhesion molecules, and other
mediators involved in the inflammatory reaction and oxida-
tive damage 
33, 34.
The level of inflammation is directly proportional to the
level of oxidative stress and capability of antioxidative
mechanisms, primarily in hepatocytes, to counteract the in-
creased production of free radicals via immune cells, such as
neutrophils and monocytal macrophageal cells 
23.
Correlation of the biochemical markers of cholestasis
and the intensity of lipid peroxidation
The values of alkaline phosphatase (AP) in the patients
with extrahepatic cholestasis caused by choledocholithiasis
were almost 7 times higher than in the control group (p <
0.001). According to the results of other authors, the increase
of AP is a reliable indicator of biliary obstruction, especially
in incomplete and segment obstructions (obstructive icterus)
where the values of bilirubin remain normal, while the values
of AP are increased 
35.
The increased activity of Ȗ-GT in the plasma of patients
with extrahepatic cholestasis found in this study, is in accor-
dance with the results of other authors 
36. This is due to the
necrosis of epithelial cells of biliary ducts (rich in Ȗ -GT) and
their proliferation leading thus to the significant increase of
Ȗ-GT activity in the serum 
37.
In the patients with extrahepatic cholestasis, there was a
significant increase in the values of total, conjugated and un-
conjugated bilirubin in the plasma, compared to the control
patients (p < 0.001). The increased values of direct bilirubin
in the plasma in cholestasis are the consequence of the in-
creased concentration gradient between the cells and plasma
or of wasting bilirubin due to the damage of the cells caused
by the obstructive bile drainage. Unlike the conjugated one
which is not toxic, the unconjugated bilirubin in free state isVolumen 70, Broj 2 VOJNOSANITETSKI PREGLED Strana 175
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very toxic to cells. Its effect is explained by the strong deter-
gent effects of biliary salts and their ability to solubilize cell
membranes 
38, 39.
The concentration of total (r = 0.87, p < 0.01), direct (r
= 0.85,  p  <  0.01) and indirect (r = 0.88,  p < 0.01)  bilirubin
shows a significant positive linear correlation with the level
of lipid peroxidation. Based on the above results, we support
the idea that bilirubin can act in vivo as efficient scavenger of
ROS and that bilirubin plays a key physiological role in cy-
toprotection against an oxidant-mediated damage 
40.
The correlation between oxidative stress and disorders of
production and secretion of bilirubin is in accordance with the
results of other authors. Namely, they have shown that a re-
duced amount of glutathione and decreased activity of gluta-
thione peroxidase in patients with cholestasis, decrease hepa-
tobiliary transport of toxic organic components 
41 leading to
the development of complications accompaning cholestasis.
The correlation between hyperbilirubinaemia and oxi-
dative stress is an expected result due to insolubilization of
cytoplasmic membrane, dysfunction of mitochondrial mem-
brane and freeing of reactive oxygen radicals 
13. Considering
the results of other authors, indicating that the products of
hems have a significant anti-inflammatory role and decrease
mortality in experimental models, the correlation between
hyperbilirubinaemia and oxidative stress can be considered
as a form of protective effect. It has been found that the
products of hems and bilirubin decrease adhesion of leuko-
cytes for the vascular endothelium as a response to oxidative
stress 
42. This is achieved by the inhibition of expression of
adhesive molecule (VCAM-1) and the reduction of inflam-
mation, increasing the risk of infection set-on 
43. Hyperbili-
rubinaemia viewed this way could represent a significant
factor that leads to immune system disorder and the devel-
opment of infection complications.
Conclusion
According to the results of this prospective study, it can
be conclude that neutrophils and the level of total, direct and
indirect bilirubin show a significant positive correlation with
the level of lipid peroxidation, measured by MDA as its final
product, while the other determined inflammatory parame-
ters and biochemical markers of cholestasis do not show
such correlation. Thus, neutrophilia and hiperbilirubinemia
observed in this way, easily established with inexpensive and
routine laboratory tests, represent an important parameter in
estimating the level of liver tissue damage in choledocholi-
thiasis.
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